Go Deep
Lantern Pharma Inc.
Lantern Pharma Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -17,634 | -0.4 | -3.10 | 0.01 | 63.16 |
| Oct 2026 | -17,639 | -0.4 | -3.10 | 0.01 | 63.31 |
| Oct 2026 | -19,345 | -0.4 | -2.98 | 0.01 | 60.81 |
| Oct 2026 | -19,398 | -0.4 | -3.05 | 0.01 | 62.24 |
| Oct 2026 | -19,495 | -0.4 | -3.18 | 0.01 | 64.74 |
| Oct 2026 | -19,343 | -0.4 | -2.97 | 0.01 | 60.48 |
Lantern Pharma Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -7,072,124.0 | -3,329,171.0 | -4,074,217.0 | -4,177,423.0 |
| EPS | -0.6 | -0.3 | — | -0.4 |
Lantern Pharma Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -17,119,438.0 | -20,781,213.0 | -15,961,534.0 | -14,259,946.0 |
| EPS | -1.6 | -1.9 | -1.5 | -1.3 |
Lantern Pharma Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 11,035,811.0 | 25,571,792.0 | 43,647,616.0 | 58,836,321.0 | — |
| Total Liabilities | 4,501,587.0 | 4,384,018.0 | 2,739,682.0 | 2,798,297.0 | — |
| Total Equity | 6,534,224.0 | 21,187,774.0 | 40,907,934.0 | 56,038,024.0 | — |
Owes vs Owns
Lantern Pharma Inc. owed $1.37 for every $1 it owned in Jun 2026, up from $0.05 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 1.37× | 0.41× | 0.17× | 0.06× | 0.05× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Lantern Pharma Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 91.7%Fixed assets (tangible) 1.0%Other assets 7.3%
How it's funded — Dec 2025
Short-term debt 0.7%Payables 40.1%Shareholders' equity 59.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 10.1 | 24.0 | 41.3 | 55.2 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.3 | 0.3 | 0.1 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.8 | 1.3 | 2.1 | 3.5 |
| Liabilities & equity | ||||
| Short-term debt | 0.1 | 0.2 | 0.2 | 0.1 |
| Long-term debt | 0.0 | 0.1 | 0.1 | 0.0 |
| Payables | 4.4 | 4.1 | 2.5 | 2.7 |
| Other liabilities | 0.0 | 0.0 | 0.0 | 0.0 |
| Shareholders' equity | 6.5 | 21.2 | 40.9 | 56.0 |
| Net tangible assets | 6.5 | 21.2 | 40.9 | 56.0 |
Lantern Pharma Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -15,676,980.0 | -17,813,201.0 | -14,346,548.0 | -12,767,492.0 | — |
| Investing Activities | 11,057,073.0 | 3,369,368.0 | -930,210.0 | 179,268.0 | — |
| Financing Activities | 1,498,240.0 | 66,710.0 | -499,997.0 | -2,182,498.0 | — |